BLNE insider grant: CFO awarded 235,000 options through 2035

Rhea-AI Filing Summary

Beeline Holdings, Inc. (BLNE) reported an insider grant: the Chief Financial Officer received stock options for 235,000 shares with an exercise price of $0.9216. The options were granted on 10/02/2025, expire on 10/02/2035, and become exercisable in equal annual installments over two years starting 05/28/2025, subject to continued service. The filing notes the grant was board‑approved and exempt from Section 16(b) under Rule 16b‑3, and the options were issued under the company’s Amended and Restated 2025 Equity Incentive Plan. Following the grant the reporting person beneficially owns 235,000 underlying shares via direct ownership of the options.

Positive

• Board‑approved grant aligns the CFO with shareholder value via long‑term options
• Moderate exercise price of $0.9216 with a long 10/02/2035 term supports retention

Negative

• Potential dilution from 235,000 underlying shares if options are exercised
• Vesting conditioned on continued service, creating retention dependency and execution risk

Insights

Compensation & Governance Analyst

New executive option grant aligns CFO incentives with long‑term share performance.

The board approved a grant of 235,000 stock options to the Chief Financial Officer with an exercise price of $0.9216 and a ten‑year term to 10/02/2035. Vesting is annual in equal amounts over two years from 05/28/2025, which frontloads some near‑term retention while preserving a multi‑year horizon.

Key dependencies include continued service as an officer for vesting and the underlying equity plan's terms. Monitor potential dilution from option exercises and any future grants that could expand the pool; the vesting schedule makes outcomes observable within 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moe Christopher R.

(Last) (First) (Middle)

188 VALLEY ST.,

SUITE 225

(Street)

PROVIDENCE RI 02909

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Beeline Holdings, Inc. [ BLNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$0.9216	10/02/2025		A		235,000		(1)	10/02/2035	Common Stock	235,000	$0	235,000	D

Explanation of Responses:

1. The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options shall vest annually in equal amounts over two years from May 28, 2025, subject to continued service as an officer on the applicable vesting dates. The stock options were granted under the Issuer's Amended and Restated 2025 Equity Incentive Plan.

	/s/ Christopher Moe	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Beeline (BLNE) disclose on this Form 4?

The CFO was granted 235,000 stock options on 10/02/2025 with an exercise price of $0.9216, exercisable through 10/02/2035, vesting annually in equal amounts over two years from 05/28/2025.

How does the vesting schedule work for the BLNE grant?

The options vest in equal annual installments over two years beginning 05/28/2025, subject to continued service as an officer on each vesting date.

Is the option grant subject to Section 16(b) short‑swing rules?

The filing states the grant was exempt under Rule 16b‑3 because it was approved by the issuer’s Board of Directors.

How many shares will the reporting person own following the transaction?

The reporting person beneficially owns 235,000 shares underlying the options following the reported grant.

What is the exercise price and term of the options?

The exercise price is $0.9216 and the options expire on 10/02/2035.